HomeBiochemistryGlycolysis Pathway: definition, Steps, Regulation, and Cancer Metabolism

Glycolysis Pathway: definition, Steps, Regulation, and Cancer Metabolism

- Advertisement -

Glycolysis is the first major pathway used by cells to extract energy from glucose. It takes place in the cytoplasm and does not require oxygen, making it essential for both aerobic and anaerobic organisms.

Through a series of enzyme-controlled reactions, one molecule of glucose is converted into two molecules of pyruvate, producing ATP and NADH. These molecules provide immediate energy and reducing power for cellular activities.

In this article, we will explore the basic concept of glycolysis, its biochemical steps, how the pathway is regulated, and why glycolysis plays a central role in cancer metabolism and disease.

Overview of Glycolysis and Its Biological Role

What Is Glycolysis?

Glycolysis is a metabolic pathway that breaks down glucose, a six-carbon sugar, into two molecules of pyruvate, each containing three carbons. The word “glycolysis” comes from Greek and means “sugar splitting.”

This pathway occurs in the cytoplasm of all living cells, from bacteria to human cells. It does not require oxygen, which allows cells to produce energy even under low-oxygen conditions.

Glycolysis serves as the main entry point for glucose into cellular metabolism and provides fast energy when cells need it.

Inputs, Outputs, and Net Energy Yield

During glycolysis, the cell invests energy first and then gains more energy later.

Main inputs:

  • 1 molecule of glucose
  • 2 molecules of ATP (energy investment)
  • 2 molecules of NAD⁺

Main outputs:

  • 2 molecules of pyruvate
  • 4 molecules of ATP (energy payoff)
  • 2 molecules of NADH
  • Water and protons

Net gain per glucose molecule:

  • 2 ATP
  • 2 NADH
  • 2 Pyruvate

This net ATP production provides immediate energy for cellular processes such as transport, biosynthesis, and movement.

Connection to Other Metabolic Pathways

Glycolysis is not an isolated pathway. Its products feed into many other metabolic processes.

  • Pyruvate can enter the mitochondria and fuel the TCA cycle under aerobic conditions.
  • When oxygen is limited, pyruvate can be converted into lactate to regenerate NAD⁺.
  • Several glycolytic intermediates feed into the pentose phosphate pathway for nucleotide synthesis and redox balance.
  • Carbon skeletons from glycolysis support amino acid and lipid biosynthesis.

Because of these connections, glycolysis acts as a central metabolic hub that supports both energy production and biosynthesis.

The Biochemical Steps of Glycolysis

Glycolysis consists of 10 enzyme-catalyzed reactions that convert glucose into pyruvate. These reactions are organized into three functional phases:

  1. Energy investment phase
  2. Cleavage phase
  3. Energy payoff phase

Each step is tightly controlled by specific enzymes.

Energy Investment Phase

In this phase, the cell uses ATP to activate glucose and trap it inside the cell.

1️⃣Step 1 – Phosphorylation of glucose

  • Enzyme: Hexokinase (or Glucokinase in liver)
  • Glucose → Glucose-6-phosphate
  • Uses 1 ATP
  • Prevents glucose from leaving the cell

2️⃣Step 2 – Isomerization

  • Enzyme: Phosphoglucose isomerase
  • Glucose-6-phosphate → Fructose-6-phosphate

3️⃣Step 3 – Second phosphorylation (committed step)

  • Enzyme: Phosphofructokinase-1 (PFK-1)
  • Fructose-6-phosphate → Fructose-1,6-bisphosphate
  • Uses 1 ATP
  • This is the rate-limiting and most regulated step of glycolysis

At the end of this phase:

  • 2 ATP are consumed
  • The sugar is activated and ready for cleavage

Cleavage Phase

The six-carbon molecule is split into two three-carbon molecules.

4️⃣Step 4 – Carbon splitting

  • Enzyme: Aldolase
  • Fructose-1,6-bisphosphate →
    • Dihydroxyacetone phosphate (DHAP)
    • Glyceraldehyde-3-phosphate (G3P)

5️⃣Step 5 – Interconversion

  • Enzyme: Triose phosphate isomerase
  • DHAP ⇌ G3P

Now, the pathway continues with two molecules of G3P per glucose.

Energy Payoff Phase

This phase generates ATP and NADH.

6️⃣Step 6 – Oxidation and NADH production

  • Enzyme: Glyceraldehyde-3-phosphate dehydrogenase
  • G3P → 1,3-bisphosphoglycerate
  • Produces NADH

7️⃣Step 7 – ATP generation

  • Enzyme: Phosphoglycerate kinase
  • Produces ATP by substrate-level phosphorylation

8️⃣Step 8 – Rearrangement

  • Enzyme: Phosphoglycerate mutase

9️⃣Step 9 – Dehydration

  • Enzyme: Enolase

🔟Step 10 – Final ATP generation

  • Enzyme: Pyruvate kinase
  • Phosphoenolpyruvate → Pyruvate
  • Produces ATP

Because two G3P molecules are processed:

  • 4 ATP are produced
  • 2 NADH are generated
  • 2 Pyruvate molecules are formed

Key Intermediates and Their Biosynthetic Roles

Several glycolytic intermediates serve as building blocks for other pathways:

  • Glucose-6-phosphate
    • Enters the pentose phosphate pathway
    • Produces NADPH and ribose
  • Fructose-6-phosphate
    • Used for amino sugar synthesis
  • 3-Phosphoglycerate
    • Precursor for serine biosynthesis
  • Pyruvate
    • Feeds into TCA cycle
    • Used for amino acid and lipid synthesis

This makes glycolysis a central supplier of metabolic precursors.

Regulation of Glycolysis

Cells tightly regulate glycolysis to match energy demand, nutrient availability, and environmental conditions. Regulation occurs mainly at three irreversible enzymatic steps and is influenced by allosteric signals, hormones, and cellular energy status.

Allosteric Regulation of Key Enzymes

Three enzymes act as control points in glycolysis.

1. Hexokinase

  • Catalyzes the first step: glucose → glucose-6-phosphate
  • Inhibited by glucose-6-phosphate (product inhibition)
  • Prevents excessive glucose trapping when the cell already has enough fuel

In liver cells, glucokinase has lower affinity for glucose and responds to blood glucose levels.

2. Phosphofructokinase-1 (PFK-1) – The Main Regulatory Enzyme

  • Controls the committed step of glycolysis
  • Highly sensitive to cellular energy status

Activators:

  • AMP and ADP (low energy signal)
  • Fructose-2,6-bisphosphate (strong activator)

Inhibitors:

  • ATP (high energy signal)
  • Citrate (abundant mitochondrial energy)

PFK-1 acts as a metabolic sensor that adjusts glycolytic flux in real time.

3. Pyruvate Kinase

  • Catalyzes the final ATP-producing step
  • Activated by fructose-1,6-bisphosphate (feed-forward activation)
  • Inhibited by ATP and alanine

This ensures coordination between early and late steps of glycolysis.

Hormonal Control of Glycolysis

Hormones regulate glycolysis at the organism level, especially in liver and muscle.

Insulin (fed state):

  • Increases glucose uptake
  • Activates PFK-2 → increases fructose-2,6-bisphosphate
  • Stimulates glycolysis

Glucagon (fasting state):

  • Decreases fructose-2,6-bisphosphate
  • Inhibits PFK-1 activity
  • Reduces glycolysis and promotes glucose release

This balance maintains blood glucose homeostasis.

Energy Status and Oxygen Availability

Glycolysis responds rapidly to the cell’s metabolic state.

  • High ATP / low AMP
    • Glycolysis slows down
  • Low ATP / high AMP
    • Glycolysis accelerates
  • NAD⁺ availability
    • Required for continuous glycolysis
    • Regenerated through mitochondrial respiration or fermentation
  • Low oxygen conditions
    • Cells rely more on glycolysis for ATP
    • Cells convert pyruvate into lactate to regenerate NAD⁺

This flexibility allows cells to survive under varying conditions.

Glycolysis in Cancer and Disease

Alterations in glycolysis are common in many diseases, especially cancer. Tumor cells reprogram their metabolism to support rapid growth, survival, and adaptation to hostile environments.

The Warburg Effect

One of the most striking features of cancer metabolism is the Warburg effect.

  • Cancer cells consume large amounts of glucose.
  • They convert glucose into lactate even when oxygen is available.
  • This process is called aerobic glycolysis.

Although aerobic glycolysis produces less ATP than mitochondrial respiration, it provides important advantages:

  • Faster ATP generation
  • Continuous supply of metabolic intermediates
  • Support for biosynthesis and redox balance

This metabolic shift is widely used as a diagnostic principle in FDG-PET imaging.

Metabolic Reprogramming in Tumor Cells

Cancer cells modify multiple components of glycolysis to increase pathway flux.

Common changes include:

  • Upregulation of glucose transporters (GLUT1, GLUT3)
  • Overexpression of glycolytic enzymes such as hexokinase II and PKM2
  • Enhanced lactate production and export
  • Acidification of the tumor microenvironment

These changes promote:

  • Cell proliferation
  • Resistance to stress
  • Immune evasion
  • Tumor invasion and metastasis

Glycolysis supports not only energy production but also anabolic growth.

Therapeutic Targeting of Glycolysis

Because cancer cells depend heavily on glycolysis, this pathway represents an attractive therapeutic target.

Potential strategies include:

  • Inhibition of glucose transporters
  • Targeting key enzymes (hexokinase, PFK-1, LDH, PKM2)
  • Blocking lactate transport
  • Combining metabolic inhibitors with chemotherapy or immunotherapy

Glycolytic enzymes and metabolites are also explored as biomarkers for diagnosis and treatment monitoring.

However, targeting glycolysis must be carefully controlled to avoid toxicity in normal tissues.

Conclusion

Glycolysis is a fundamental metabolic pathway that allows cells to convert glucose into usable energy and essential metabolic intermediates. Beyond ATP production, it supports biosynthesis, redox balance, and cellular homeostasis.

The pathway is tightly regulated by enzymes, hormones, and cellular energy status, ensuring metabolic flexibility under changing conditions. In cancer, glycolysis becomes reprogrammed to sustain rapid growth and survival, making it a key target for diagnosis and therapy.

Understanding glycolysis provides a strong biochemical foundation for exploring metabolism, disease mechanisms, and emerging therapeutic strategies in cancer biology.

- Advertisement -
Mohamed NAJID
Mohamed NAJID
Mohamed Najid is a PhD student in Cancer Cell Biology with a Master’s degree in Cancer Biology. His research focuses on circulating tumor cells (CTCs) in bladder cancer and their role as emerging diagnostic biomarkers.He creates clear, science-based content to help readers understand medical tests, cancer biology, and everyday health topics—without the confusion.ResearchGate: https://www.researchgate.net/profile/Mohamed-Najid-2 ORCID: https://orcid.org/0009-0002-7491-3366
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular